Latest & greatest articles for opioid

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on opioid or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on opioid and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for opioid

127. Primary Care-Based Models for the Treatment of Opioid Use Disorder: A Scoping Review.

Primary Care-Based Models for the Treatment of Opioid Use Disorder: A Scoping Review. Greater integration of medication-assisted treatment (MAT) for opioid use disorder (OUD) in U.S. primary care settings would expand access to treatment for this condition. Models for integrating MAT into primary care vary in structure. This article summarizes findings of a technical report for the Agency for Healthcare Research and Quality describing MAT models of care for OUD, based on a literature review

Annals of Internal Medicine2016

128. Chest compressions and rescue breathing when administering naloxone in opioid overdose

Chest compressions and rescue breathing when administering naloxone in opioid overdose Chest compressions and rescue breathing when administering naloxone in opioid overdose | The Ontario HIV Treatment Network Chest compressions and rescue breathing when administering naloxone in opioid overdose Chest compressions and rescue breathing when administering naloxone in opioid overdose Questions What does the evidence say about the use of chest compressions and/or the use of rescue breathing when (...) responding to an opioid overdose and administering naloxone? Key take-home messages • Opioid overdoses cause respiratory failure (a reduction or stop in breathing), which can lead to cardiac arrest (1, 2). In the event of a suspected opioid overdose, bystanders should call 911 and administer naloxone before any attempts at resuscitation (3-5). Various expert groups have differing opinions on the appropriateness of using chest compressions only, rescue breathing only or chest compressions combined

Ontario HIV Treatment Network2016

130. Injectable Non-Opioid Pain Relievers for Acute Pain in the Pre-Hospital Setting: Clinical Effectiveness and Guidelines

Injectable Non-Opioid Pain Relievers for Acute Pain in the Pre-Hospital Setting: Clinical Effectiveness and Guidelines Injectable Non-Opioid Pain Relievers for Acute Pain in the Pre-Hospital Setting: Clinical Effectiveness and Guidelines | CADTH.ca Find the information you need Injectable Non-Opioid Pain Relievers for Acute Pain in the Pre-Hospital Setting: Clinical Effectiveness and Guidelines Injectable Non-Opioid Pain Relievers for Acute Pain in the Pre-Hospital Setting: Clinical (...) Effectiveness and Guidelines Published on: December 1, 2016 Project Number: RB1041-000 Product Line: Research Type: Drug Report Type: Summary of Abstracts Result type: Report Question What is the clinical effectiveness of injectable non-opioid pain relievers for the management of acute pain in the pre-hospital setting? What are the evidence-based guidelines regarding the use of injectable non-opioid pain relievers for the management of acute pain in the pre-hospital setting? Key Message One systematic

Canadian Agency for Drugs and Technologies in Health - Rapid Review2016

131. Pain Management and Use of Opioids in Pediatric Oncology in India: A Qualitative Approach

Pain Management and Use of Opioids in Pediatric Oncology in India: A Qualitative Approach 28831441 2018 11 13 2378-9506 3 4 2017 Aug Journal of global oncology J Glob Oncol Pain Management and Use of Opioids in Pediatric Oncology in India: A Qualitative Approach. 331-337 10.1200/JGO.2016.003483 Consumption of medical opium for pain relief in India is low, despite the country being one of the main world producers of the substance. We investigated obstacles to opioid use and physician perceptions (...) institutions. The main obstacles identified were lack of financial resources, inadequate education of health care providers on pain management, insufficient human resources (particularly lack of dedicated trained oncology nurses), poor access to opioids, and cultural perceptions about pain. Children from rural areas, treated in public hospitals, and from lower socioeconomic classes appear disadvantaged. A significant equality gap exists between public institutions and private institutions, which provide

Journal of global oncology2016 Full Text: Link to full Text with Trip Pro

132. Incident opioid drug use and adverse respiratory outcomes among older adults with COPD

Incident opioid drug use and adverse respiratory outcomes among older adults with COPD 27418553 2016 09 01 2016 09 01 1399-3003 48 3 2016 Sep The European respiratory journal Eur. Respir. J. Incident opioid drug use and adverse respiratory outcomes among older adults with COPD. 683-93 10.1183/13993003.01967-2015 We evaluated risk of adverse respiratory outcomes associated with incident opioid use among older adults with chronic obstructive pulmonary diseases (COPD).This was a retrospective (...) population-based cohort study using a validated algorithm applied to health administrative data to identify adults aged 66 years and older with COPD. Inverse probability of treatment weighting using the propensity score was used to estimate hazard ratios comparing adverse respiratory outcomes within 30 days of incident opioid use compared to controls.Incident opioid use was associated with significantly increased emergency room visits for COPD or pneumonia (HR 1.14, 95% CI 1.00-1.29; p=0.04), COPD or

EvidenceUpdates2016

133. Opioid use after propofol or sevoflurane anesthesia: a randomized trial

Opioid use after propofol or sevoflurane anesthesia: a randomized trial 27638296 2016 09 30 2017 03 23 2017 03 23 1496-8975 63 11 2016 Nov Canadian journal of anaesthesia = Journal canadien d'anesthesie Can J Anaesth Opioid use after propofol or sevoflurane anesthesia: a randomized trial. 1258-65 10.1007/s12630-016-0728-5 The intravenous anesthetic propofol is a gamma-aminobutyric acid A receptor agonist. Propofol promotes analgesia by depressing nociceptive transmission in peripheral neurons (...) , antagonizing N-methyl-D-aspartate receptors, and activating gamma-aminobutyric acid A receptors in dorsal root ganglion receptor cells. Nevertheless, it remains unclear whether intraoperative propofol causes clinically meaningful postoperative analgesia. We therefore tested the hypothesis that patients anesthetized with sevoflurane require a greater quantity of postoperative opioids (from the end of surgery until the next postoperative morning) than those anesthetized with propofol. With Institutional

EvidenceUpdates2016

134. Opioids Out, Cannabis In Negotiating the Unknowns in Patient Care for Chronic Pain

Opioids Out, Cannabis In Negotiating the Unknowns in Patient Care for Chronic Pain 27802551 2016 12 13 2018 11 13 1538-3598 316 17 2016 Nov 01 JAMA JAMA Opioids Out, Cannabis In: Negotiating the Unknowns in Patient Care for Chronic Pain. 1763-1764 10.1001/jama.2016.13677 Choo Esther K EK Center for Policy and Research in Emergency Medicine, Oregon Health & Science University, Portland. Feldstein Ewing Sarah W SW Department of Psychiatry, Oregon Health & Science University, Portland. Lovejoy (...) Travis I TI Department of Psychiatry, Oregon Health & Science University, Portland3Center to Improve Veteran Involvement in Care, VA Portland Health Care System, Portland, Oregon. eng IK2 HX001516 HX HSRD VA United States K23 DA031881 DA NIDA NIH HHS United States R01 AA023658 AA NIAAA NIH HHS United States 3R01AA023658-02S1 International Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S. United States JAMA 7501160 0098-7484 0 Analgesics 0 Analgesics, Opioid

JAMA2016 Full Text: Link to full Text with Trip Pro

135. Use of biological samples in rehabilitation of persons receiving opioid maintenance treatment: a systematic review

Use of biological samples in rehabilitation of persons receiving opioid maintenance treatment: a systematic review Use of biological samples in rehabilitation of persons receiving opioid mainte-nance treatment: a systematic review - Nasjonalt kunnskapssenter for helsetjenesten Main menu Menu The Knowledge Centre for the Health Services is part of the Norwegian Institute of Public Health since January 1, 2016. For new publications, please go to Search Rapport fra Folkehelseinstituttet (...) - Systematisk oversikt Use of biological samples in rehabilitation of persons receiving opioid mainte-nance treatment: a systematic review Published 22/09/2016 Hov L, Mosdøl A, Ding Y, Strømme H, Vist GE. Use of biological samples in rehabilitation of persons receiving opioid mainte-nance treatment: a systematic review. Rapport fra Folkehelseinstituttet – 2016. ISBN 978-82-8082-767-8 Key messages Opioid maintenance treatment is the most common form of treatment for people with opioid dependence in Norway

The Norwegian Knowledge Centre for the Health Services2016

136. Intravenous nalbuphine 50 microg.kg(-1) is ineffective for opioid-induced pruritus in pediatrics

Intravenous nalbuphine 50 microg.kg(-1) is ineffective for opioid-induced pruritus in pediatrics 27518236 2016 08 13 2016 08 17 2016 08 13 0832-610X 53 11 2006 Nov Canadian journal of anaesthesia = Journal canadien d'anesthesie Can J Anaesth Intravenous nalbuphine 50 µg·kg(-1) is ineffective for opioid-induced pruritus in pediatrics. 1103-10 10.1007/BF03022878 This investigation evaluated the efficacy of nalbuphine in treating postoperative opioid-induced pruritus (Pr) in pediatric patients (...) . After Ethics Board approval, the dual site, tertiary care teaching centre study recruited 212 subjects, age ≥ seven years, who received opioid analgesia postoperatively. A modified, self-report colour analogue scale (CAS) scored pruritus intensity (PrI). Subjects who reported PrI score ≥ 5/10 were randomized to treatment with nalbuphine 50 µg·kg(-1) iv (max 5 mg) or saline placebo. A pruritus intensity difference (PrID) ≥ 50% was considered a positive outcome. Of 260 subjects approached, 212

EvidenceUpdates2016

137. Traditional opioids for chronic non-cancer pain: untidy, unsatisfactory, and probably unsuitable

Traditional opioids for chronic non-cancer pain: untidy, unsatisfactory, and probably unsuitable Traditional opioids for chronic non-cancer pain: untidy, unsatisfactory, and probably unsuitable - Evidently Cochrane Search and hit Go By September 23, 2016 // In this guest blog, Consultant in Pain Medicine Cathy Stannard and pain researcher Andrew Moore discuss some unpalatable truths about traditional opioids for chronic non-cancer pain. What are opioids? There are two main types of opioids (...) . Traditional opioids, which we discuss here, are drugs that work only on opioid receptors in the nervous system; they include morphine, hydromorphone, codeine, hydrocodeine, methadone, oxycodone, fentanyl, and buprenorphine. Some opioids (tramadol, tapentadol) have additional methods of action, and need to be considered separately on another occasion. What is chronic non-cancer pain? If you ignore pain lasting less than three months, and headache, and cancer pain, then what you have left is chronic pain

Evidently Cochrane2016

138. Physician Capacity to Treat Opioid Use Disorder With Buprenorphine-Assisted Treatment

Physician Capacity to Treat Opioid Use Disorder With Buprenorphine-Assisted Treatment 27654608 2018 11 13 1538-3598 316 11 2016 Sep 20 JAMA JAMA Physician Capacity to Treat Opioid Use Disorder With Buprenorphine-Assisted Treatment. 1211-1212 10.1001/jama.2016.10542 Stein Bradley D BD RAND Corporation, Pittsburgh, Pennsylvania2University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. Sorbero Mark M RAND Corporation, Pittsburgh, Pennsylvania. Dick Andrew W AW RAND Corporation, Boston

JAMA2016 Full Text: Link to full Text with Trip Pro

139. Intranasal and Intramuscular Naloxone for Opioid Overdose in the Pre-Hospital Setting: Comparative Clinical Effectiveness and Cost-Effectiveness

Intranasal and Intramuscular Naloxone for Opioid Overdose in the Pre-Hospital Setting: Comparative Clinical Effectiveness and Cost-Effectiveness Intranasal and Intramuscular Naloxone for Opioid Overdose in the Pre-Hospital Setting: Comparative Clinical Effectiveness and Cost-Effectiveness | CADTH.ca Find the information you need Intranasal and Intramuscular Naloxone for Opioid Overdose in the Pre-Hospital Setting: Comparative Clinical Effectiveness and Cost-Effectiveness Intranasal (...) and Intramuscular Naloxone for Opioid Overdose in the Pre-Hospital Setting: Comparative Clinical Effectiveness and Cost-Effectiveness Published on: September 7, 2016 Project Number: RA0863-000 Product Line: Research Type: Drug Report Type: Reference List Result type: Report Question What is the comparative clinical effectiveness of pre-filled intranasal naloxone versus intramuscular naloxone? What is the comparative clinical effectiveness of pre-filled intranasal naloxone versus naloxone administered

Canadian Agency for Drugs and Technologies in Health - Rapid Review2016

140. Buprenorphine/Naloxone Versus Methadone for the Treatment of Opioid Dependence: A Review of Comparative Clinical Effectiveness, Cost-Effectiveness and Guidelines

Buprenorphine/Naloxone Versus Methadone for the Treatment of Opioid Dependence: A Review of Comparative Clinical Effectiveness, Cost-Effectiveness and Guidelines Buprenorphine/Naloxone Versus Methadone for the Treatment of Opioid Dependence: A Review of Comparative Clinical Effectiveness, Cost-Effectiveness and Guidelines | CADTH.ca Find the information you need Buprenorphine/Naloxone Versus Methadone for the Treatment of Opioid Dependence: A Review of Comparative Clinical Effectiveness, Cost (...) -Effectiveness and Guidelines Buprenorphine/Naloxone Versus Methadone for the Treatment of Opioid Dependence: A Review of Comparative Clinical Effectiveness, Cost-Effectiveness and Guidelines Published on: September 2, 2016 Project Number: RD0032-000 Product Line: Research Type: Drug Report Type: Peer-reviewed summary with critical appraisal Result type: Report Question What is the clinical effectiveness of buprenorphine/naloxone compared with methadone for the treatment of patients with opioid dependence

Canadian Agency for Drugs and Technologies in Health - Rapid Review2016